Is a complete PBYI research report available?

No complete published report is available for Puma Biotechnology, Inc. (PBYI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · USD

$10.7

-0.22 (-2.0%)· Recorded snapshot

Market cap	552.3M
Revenue (ttm)	231.2M
Net income (ttm)	26.7M
EPS (ttm)	$0.50
Shares out	51.6M
P/E (trailing)	21.2x
Volume	328,293
Beta	1.21

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 231.2M
Net income (ttm): 26.7M
EPS (ttm): $0.50
P/E (trailing): 21.2x
Market cap: 552.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001401667
Company name	Puma Biotechnology, Inc.
Country	United States
Country code	US
CUSIP number	74587V107
Earnings date	2026-11-05
Earnings time	amc
Employees	179
Employees change	7
Employees growth	4.07%
Enterprise value	$463.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US74587V1070
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$552.3M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$10.70
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PBYI
U.S. state	California
Website	https://www.pumabiotechnology.com

Metric

Value

Amount currency

USD

CIK code

0001401667

Company name

Puma Biotechnology, Inc.

Country

United States

Country code

CUSIP number

74587V107

Earnings date

2026-11-05

Earnings time

amc

Employees

179

Employees change

Employees growth

4.07%

Enterprise value

$463.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US74587V1070

Last 10-K release date

2026-02-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$552.3M

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$10.70

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PBYI

U.S. state

California

Website

https://www.pumabiotechnology.com

Metric	Value
Adjusted P/E ratio	16.21x
Average P/E ratio (3Y)	11.76x
Average P/E ratio (5Y)	6,546.88x
Earnings yield	4.71%
EV/Earnings	17.33x
EV/EBIT	15.21x
EV/EBITDA	11.54x
EV/FCF	11.25x
EV/Sales	2x
FCF / EV yield	8.89%
FCF yield	7.46%
Forward EV/Sales	3.71x
Forward P/S	4.43x
Graham number	5.54232
Graham upside	-48.18%
P/(FCF - SBC) ratio	16.23x
P/(OCF - SBC) ratio	16.23x
P/B ratio	4.03x
P/E ratio	21.25x
P/FCF ratio	13.41x
P/OCF ratio	13.42x
P/S ratio	2.39x
Price / tangible book value	5.41x
Price/EBITDA ratio	13.76x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

16.21x

Average P/E ratio (3Y)

11.76x

Average P/E ratio (5Y)

6,546.88x

Earnings yield

4.71%

EV/Earnings

17.33x

EV/EBIT

15.21x

EV/EBITDA

11.54x

EV/FCF

11.25x

EV/Sales

FCF / EV yield

8.89%

FCF yield

7.46%

Forward EV/Sales

3.71x

Forward P/S

4.43x

Graham number

5.54232

Graham upside

-48.18%

P/(FCF - SBC) ratio

16.23x

P/(OCF - SBC) ratio

16.23x

P/B ratio

4.03x

P/E ratio

21.25x

P/FCF ratio

13.41x

P/OCF ratio

13.42x

P/S ratio

2.39x

Price / tangible book value

5.41x

Price/EBITDA ratio

13.76x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	13.16%
EBITDA margin	17.35%
Effective tax rate	14.28%
FCF margin	17.8%
Gross margin	74.83%
Operating margin	13.16%
Pretax margin	13.48%
Profit margin	11.55%
Profit per employee	$149,263
Profitable quarters	1
Profitable years	4
Revenue per employee	$1.3M
ROA	9.81%
ROA (5Y)	7.5%
ROCE	21.3%
ROE	21.97%
ROIC	56.55%
ROIC (5Y)	29.76%
SBC / revenue	3.09%
Tax / revenue	1.92%

Metric

Value

EBIT margin

13.16%

EBITDA margin

17.35%

Effective tax rate

14.28%

FCF margin

17.8%

Gross margin

74.83%

Operating margin

13.16%

Pretax margin

13.48%

Profit margin

11.55%

Profit per employee

$149,263

Profitable quarters

Profitable years

Revenue per employee

$1.3M

ROA

9.81%

ROA (5Y)

7.5%

ROCE

21.3%

ROE

21.97%

ROIC

56.55%

ROIC (5Y)

29.76%

SBC / revenue

3.09%

Tax / revenue

1.92%

Metric	Value
EPS growth	-48.22%
EPS growth (Q)	35.82%
EPS growth quarters	1
EPS growth years	0
FCF growth	-6.93%
FCF growth (Q)	-88.45%
FCF growth (QoQ)	-89.47%
FCF growth 3Y	10.13%
FCF growth 5Y	28.74%
Gross profit growth	0.5%
Gross profit growth (Q)	9.7%
Gross profit growth 3Y	-0.51%
Gross profit growth 5Y	-4.02%
Net income growth	-44.86%
Net income growth (Q)	39.86%
Net income growth quarters	1
Net income growth years	8
OCF growth	-7.2%
OCF growth (Q)	-88.47%
OCF growth (QoQ)	-89.47%
OCF growth 3Y	10.04%
OCF growth 5Y	28.66%
Operating income growth	-33.93%
Operating income growth (Q)	14.3%
Operating income growth 3Y	4.51%
Operating income growth 5Y	196.87%
Revenue growth	-2.86%
Revenue growth (Q)	7.75%
Revenue growth (QoQ)	26.08%
Revenue growth 3Y	0.16%
Revenue growth 5Y	-1.93%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth

-48.22%

EPS growth (Q)

35.82%

EPS growth quarters

EPS growth years

FCF growth

-6.93%

FCF growth (Q)

-88.45%

FCF growth (QoQ)

-89.47%

FCF growth 3Y

10.13%

FCF growth 5Y

28.74%

Gross profit growth

0.5%

Gross profit growth (Q)

9.7%

Gross profit growth 3Y

-0.51%

Gross profit growth 5Y

-4.02%

Net income growth

-44.86%

Net income growth (Q)

39.86%

Net income growth quarters

Net income growth years

OCF growth

-7.2%

OCF growth (Q)

-88.47%

OCF growth (QoQ)

-89.47%

OCF growth 3Y

10.04%

OCF growth 5Y

28.66%

Operating income growth

-33.93%

Operating income growth (Q)

14.3%

Operating income growth 3Y

4.51%

Operating income growth 5Y

196.87%

Revenue growth

-2.86%

Revenue growth (Q)

7.75%

Revenue growth (QoQ)

26.08%

Revenue growth 3Y

0.16%

Revenue growth 5Y

-1.93%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$10,000
Depreciation and amortization	$9.7M
EBIT	$30.4M
EBITDA	$40.1M
EPS	$0.50
FCF per share	$0.80
Financing cash flow	$-45.3M
Free cash flow	$41.2M
Free cash flow minus SBC	$34M
Gross profit	$173M
Income taxes	$4.5M
Investing cash flow	$-16M
Net borrowing	$-44.5M
Net cash flow	$-20.2M
Net income	$26.7M
Operating cash flow minus SBC	$34M
Operating income	$30.4M
Revenue	$231.2M
Stock-based compensation	$7.1M

Metric

Value

Capital expenditures

$10,000

Depreciation and amortization

$9.7M

EBIT

$30.4M

EBITDA

$40.1M

EPS

$0.50

FCF per share

$0.80

Financing cash flow

$-45.3M

Free cash flow

$41.2M

Free cash flow minus SBC

$34M

Gross profit

$173M

Income taxes

$4.5M

Investing cash flow

$-16M

Net borrowing

$-44.5M

Net cash flow

$-20.2M

Net income

$26.7M

Operating cash flow minus SBC

$34M

Operating income

$30.4M

Revenue

$231.2M

Stock-based compensation

$7.1M

Metric	Value
Altman Z-Score	-3.73
Book value per share	$2.71
Debt / EBITDA	0.11
Debt / equity	0.03
Debt / FCF	0.12
Interest coverage	8.65
Long-term assets	$47.7M
Long-term liabilities	$4.4M
Net cash (debt)	$89.1M
Net cash / market cap	16.14%
Net cash growth	90.38%
Net debt / EBITDA	-2.22
Net debt / equity	-0.64
Net debt / FCF	-2.16
Piotroski F-Score	7
Property, plant and equipment	$4.5M
Shareholders' equity	$138.5M
Tangible book value	$102M
Tangible book value per share	$2.00
Total assets	$192.7M
Total cash	$93.9M
Total debt	$4.8M
Total liabilities	$54.2M
WACC	11.35%

Metric

Value

Altman Z-Score

-3.73

Book value per share

$2.71

Debt / EBITDA

0.11

Debt / equity

0.03

Debt / FCF

0.12

Interest coverage

8.65

Long-term assets

$47.7M

Long-term liabilities

$4.4M

Net cash (debt)

$89.1M

Net cash / market cap

16.14%

Net cash growth

90.38%

Net debt / EBITDA

-2.22

Net debt / equity

-0.64

Net debt / FCF

-2.16

Piotroski F-Score

Property, plant and equipment

$4.5M

Shareholders' equity

$138.5M

Tangible book value

$102M

Tangible book value per share

$2.00

Total assets

$192.7M

Total cash

$93.9M

Total debt

$4.8M

Total liabilities

$54.2M

WACC

11.35%

Metric	Value
Asset turnover	1.19
Current assets	$145.1M
Current liabilities	$49.8M
Current ratio	2.91
Inventory turnover	5.31
Net working capital	$1.8M
Quick ratio	2.57
Working capital	$95.2M
Working capital turnover	3.03

Metric

Value

Asset turnover

1.19

Current assets

$145.1M

Current liabilities

$49.8M

Current ratio

2.91

Inventory turnover

5.31

Net working capital

$1.8M

Quick ratio

2.57

Working capital

$95.2M

Working capital turnover

3.03

Metric	Value
Buyback yield / dilution	-3.62%
Dividend yield	0%
Shareholder yield	-3.62%

Metric

Value

Buyback yield / dilution

-3.62%

Dividend yield

Shareholder yield

-3.62%

Metric	Value
10Y price change	-73.15%
10Y return CAGR	-12.32%
10Y total return	-73.15%
150-day SMA	$8.32
1D price change	-2.01%
1M price change	8.7%
1M total return	8.7%
1W price change	-1.3%
1W total return	-1.3%
1Y price change	101.52%
1Y return CAGR	101.62%
1Y total return	101.52%
20-day SMA	$10.30
200-day SMA	$7.87
3M price change	32.92%
3M total return	32.92%
3Y price change	342.5%
3Y return CAGR	64.16%
3Y total return	342.5%
50-day SMA	$9.77
50-day SMA vs 200-day SMA	50over200
52-week high	$11.50
52-week high date	2026-10-23
52-week low	$4.58
52-week low date	2025-11-11
5Y price change	103.06%
5Y return CAGR	15.22%
5Y total return	103.06%
6M price change	41.41%
6M total return	41.41%
All-time high	$279.37
All-time high date	2014-08-26
All-time low	$1.60
All-time low date	2022-05-11
Average true range (ATR)	$0.45
Average volume	365.3K
Beta (1Y)	0.69
Beta (2Y)	1.07
Beta (5Y)	1.21
Change from 52-week high	-6.96%
Change from 52-week low	133.88%
Change from all-time high	-96.2%
Change from all-time low	563.75%
Change from open	-1.11%
Day's gap	-0.92%
Dollar volume	$3.5M
High price	$10.90
Low price	$10.59
Monthly RSI	75.52
Open price	$10.82
Position in 52-week range	35.48%
Premarket change	0.73%
Premarket close	$10.92
Premarket price	$11.00
Previous close	$10.92
Price vs 150-day SMA	27.63%
Price vs 20-day SMA	3.07%
Price vs 200-day SMA	34.91%
Price vs 50-day SMA	8.72%
Relative volume	0.9
RSI	56.11
Sharpe ratio	1.43
Sharpe ratio (3Y)	1.02
Sharpe ratio (5Y)	0.48
Sortino ratio	2.12
Sortino ratio (3Y)	1.66
Sortino ratio (5Y)	0.81
Volume	328.3K
Weekly RSI	66.43
YTD price change	78.49%
YTD total return	78.49%

Metric

Value

10Y price change

-73.15%

10Y return CAGR

-12.32%

10Y total return

-73.15%

150-day SMA

$8.32

1D price change

-2.01%

1M price change

8.7%

1M total return

8.7%

1W price change

-1.3%

1W total return

-1.3%

1Y price change

101.52%

1Y return CAGR

101.62%

1Y total return

101.52%

20-day SMA

$10.30

200-day SMA

$7.87

3M price change

32.92%

3M total return

32.92%

3Y price change

342.5%

3Y return CAGR

64.16%

3Y total return

342.5%

50-day SMA

$9.77

50-day SMA vs 200-day SMA

50over200

52-week high

$11.50

52-week high date

2026-10-23

52-week low

$4.58

52-week low date

2025-11-11

5Y price change

103.06%

5Y return CAGR

15.22%

5Y total return

103.06%

6M price change

41.41%

6M total return

41.41%

All-time high

$279.37

All-time high date

2014-08-26

All-time low

$1.60

All-time low date

2022-05-11

Average true range (ATR)

$0.45

Average volume

365.3K

Beta (1Y)

0.69

Beta (2Y)

1.07

Beta (5Y)

1.21

Change from 52-week high

-6.96%

Change from 52-week low

133.88%

Change from all-time high

-96.2%

Change from all-time low

563.75%

Change from open

-1.11%

Day's gap

-0.92%

Dollar volume

$3.5M

High price

$10.90

Low price

$10.59

Monthly RSI

75.52

Open price

$10.82

Position in 52-week range

35.48%

Premarket change

0.73%

Premarket close

$10.92

Premarket price

$11.00

Previous close

$10.92

Price vs 150-day SMA

27.63%

Price vs 20-day SMA

3.07%

Price vs 200-day SMA

34.91%

Price vs 50-day SMA

8.72%

Relative volume

0.9

RSI

56.11

Sharpe ratio

1.43

Sharpe ratio (3Y)

1.02

Sharpe ratio (5Y)

0.48

Sortino ratio

2.12

Sortino ratio (3Y)

1.66

Sortino ratio (5Y)

0.81

Volume

328.3K

Weekly RSI

66.43

YTD price change

78.49%

YTD total return

78.49%

Metric	Value
Float	40.3M
Float percentage	78.16%
Shares change (QoQ)	3.44%
Shares change (YoY)	3.62%
Shares held by insiders	13.84%
Shares held by institutions	67.78%
Shares outstanding	51.6M
Short % of float	10.57%
Short % of shares	8.26%
Short ratio	13.8 days

Metric

Value

Float

40.3M

Float percentage

78.16%

Shares change (QoQ)

3.44%

Shares change (YoY)

3.62%

Shares held by insiders

13.84%

Shares held by institutions

67.78%

Shares outstanding

51.6M

Short % of float

10.57%

Short % of shares

8.26%

Short ratio

13.8 days

Puma Biotechnology, Inc. (PBYI)

Price

Financial snapshot

Fair-value bridge

Latest news · PBYI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PBYI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PBYI

Frequently asked questions